Pierandrea Muglia
Directeur/Membre du Conseil chez SANA AB
Postes actifs de Pierandrea Muglia
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SANA AB | Directeur/Membre du Conseil | 01/01/2023 | - |
| Independent Dir/Board Member | 01/01/2023 | - |
Historique de carrière de Pierandrea Muglia
Anciens postes connus de Pierandrea Muglia
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| GRIN Therapeutics, Inc. | Fondateur | 01/09/2021 | 01/09/2022 |
| President | 01/09/2021 | 01/09/2022 | |
UCB Pharma SA (Belgium)
 UCB Pharma SA (Belgium) Pharmaceuticals: MajorHealth Technology UCB Pharma SA discovers and develops biopharmaceutical products. It is a biopharmaceutical company focuses on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. The company is headquartered in Brussels, Belgium. | Corporate Officer/Principal | 01/09/2012 | 01/10/2019 |
Handl Therapeutics BV
 Handl Therapeutics BV BiotechnologyHealth Technology Handl Therapeutics BV engages in the provision of gene therapy treatment solutions. It develops medicine for the treatment of complex neurodegenerative diseases. The company was founded by Florent Gros and Michael R. Linden in 2019 and is headquartered in Louvain, Belgium. | Sales & Marketing | - | - |
| NTG NORDIC TRANSPORT GROUP A/S | Directeur/Membre du Conseil | 28/05/2010 | 28/05/2010 |
| Corporate Officer/Principal | 28/05/2010 | - |
Statistiques
Internationale
| Danemark | 3 |
| Belgique | 3 |
| Etats-Unis | 2 |
Opérationnelle
| Director/Board Member | 2 |
| Corporate Officer/Principal | 2 |
| Independent Dir/Board Member | 1 |
Sectorielle
| Health Technology | 4 |
| Transportation | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| NTG NORDIC TRANSPORT GROUP A/S | Transportation |
| SANA AB | Health Technology |
| Entreprise privées | 3 |
|---|---|
Handl Therapeutics BV
Handl Therapeutics BV BiotechnologyHealth Technology Handl Therapeutics BV engages in the provision of gene therapy treatment solutions. It develops medicine for the treatment of complex neurodegenerative diseases. The company was founded by Florent Gros and Michael R. Linden in 2019 and is headquartered in Louvain, Belgium. | Health Technology |
| GRIN Therapeutics, Inc. | |
UCB Pharma SA (Belgium)
UCB Pharma SA (Belgium) Pharmaceuticals: MajorHealth Technology UCB Pharma SA discovers and develops biopharmaceutical products. It is a biopharmaceutical company focuses on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. The company is headquartered in Brussels, Belgium. | Health Technology |
- Bourse
- Insiders
- Pierandrea Muglia
- Expérience
